BOC Sciences - Products
London
BOC Sciences provides various research (bio)chemicals: inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities, metabolites, APIs, natural compounds, ADCs, and chiral compounds.
| Product | Description | |
|---|---|---|
| ML 297 | ML 297 is a Kir3.1/3.2 (GIRK1/2) channel activator with IC50 values of 160, 887 and 914 nM for GIRK1/2, GIRK1/4 and GIRK1/3. Group: Pharmaceutical. CAS No. 1443246-62-5. Pack Sizes: 100 mg. Product ID: B2693-169428. Molecular formula: Custom synthesis is available. Send your inquiries for more information. |  London |
| ML324 | ML324 exhibits good Caco-2 cell permeability, and possesses excellent microsomal stability in the presence of both mouse and rat liver microsomes. Group: Pharmaceutical. CAS No. 1222800-79-4. Pack Sizes: 300 mg. Product ID: B0084-463376. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 385 | ML 385 is a novel and specific inhibitor of nuclear factor erythroid 2-related factor 2 (Nrf2; IC50 = 1.9 μM). ML 385 blocks NRF2 transcriptional activity, and enhances the efficacy of carboplatin as well as other chemotherapeutic drugs in lung cancer cells (NSCLC). Group: Pharmaceutical. CAS No. 846557-71-9. Pack Sizes: 100 mg. Product ID: B0084-007736. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML390 | ML-390 is an inhibitor of human DHODH, which induces differentiation in acute myeloid leukemia cell lines U937 (murine) and THP-1 (human) cell lines with an EC50 value of approximately 2 μM. Group: Pharmaceutical. CAS No. 2029049-79-2. Pack Sizes: 100 mg. Product ID: B0084-008137. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML 67-33 | ML 67-33 is a K2P potassium channel activator that increases channel currents by activating core gating apparatus of channels. Group: Pharmaceutical. CAS No. 1443290-89-8. Pack Sizes: 25 mg. Product ID: B1370-291155. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MLN0128 | MLN0128, also known as INK128, is a TORC1/2 inhibitor, is also an orally bioavailable inhibitor of raptor-mTOR (TOR complex 1 or TORC1) and rictor-mTOR (TOR complex 2 or TORC2) with potential antineoplastic activity. TORC1/2 inhibitor INK128 binds to and inhibits both TORC1 and TORC2 complexes of mTOR, which may result in tumor cell apoptosis and a decrease in tumor cell proliferation. TORC1 and 2 are upregulated in some tumors and play an important role in the PI3K/Akt/mTOR signaling pathway, which is frequently dysregulated in human cancers. Group: Pharmaceutical. CAS No. 1224844-38-5. Pack Sizes: 100 mg. Product ID: B2693-453595. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML SA1 | ML SA1 is an activator of TRPML channels. It can induce TRPML-mediated Ca2+ release from lysosomes and reduce cholesterol accumulation in Niemann-Pick type C macrophages. Group: Pharmaceutical. CAS No. 332382-54-4. Pack Sizes: 1 g. Product ID: B2693-169420. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| ML-SI3 | ML-SI3 is an antagonist of the TRPML family of calcium channels. ML-SI3 can prevent lysosomal calcium efflux and has been reported to block downstream TRPML1-mediated induction of autophagy. Group: Pharmaceutical. CAS No. 891016-02-7. Pack Sizes: 100 mg. Product ID: B1370-330907. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAD | Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload and antibody drug conjugate. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 203849-91-6. Pack Sizes: 10 mg. Product ID: BADC-00309. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAE | Monomethyl Auristatin E (MMAE) is a synthetic analog of dolastatin 10 that similarly inhibits tubulin polymerization and exhibits potent cytotoxicity. It is commonly conjugated with monoclonal antibodies directed at antigens specific to cancer cells for tumor-directed cytotoxicity. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 474645-27-7. Pack Sizes: 25 mg. Product ID: BBF-05782. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAE-[d8] | MMAE-[d8] is a labelled analogue of MMAE, which is a potent mitotic inhibitor and a tubulin inhibitor. Group: Pharmaceutical. CAS No. 2070009-72-0. Pack Sizes: 10 mg. Product ID: BLP-012288. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MMAF | Monomethyl auristatin F (MMAF) is a synthetic antineoplastic agent. It is part of some experimental anti-cancer antibody-drug conjugates such as vorsetuzumab mafodotin and SGN-CD19A. In International Nonproprietary Names for MMAF-antibody-conjugates, the name mafodotin refers to MMAF plus its attachment structure to the antibody. Uses: Adcs cytotoxin. Group: Pharmaceutical. CAS No. 745017-94-1. Pack Sizes: 10 mg. Product ID: BBF-05779. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| m-Methoxytopolin riboside | It can be used in biological study in influence of plant growth regulators on shoot proliferation and secondary metabolite production in micropropagated Huernia hystrix. Group: Pharmaceutical. CAS No. 101565-95-1. Pack Sizes: 1 g. Product ID: B2706-291769. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moclobemide | Moclobemide is a reversible monoamine oxidase A (MAO-A) inhibitor, displaying antidepressive activity. Group: Pharmaceutical. CAS No. 71320-77-9. Pack Sizes: 100 mg. Product ID: B0084-075760. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moclobemide Impurities | Moclobemide Impurities play a significant role in quality control and analysis within the pharmaceutical industry, particularly for antidepressant medications. They are critical in ensuring the efficacy and safety of Moclobemide, a monoamine oxidase inhibitor used to treat depression and social anxiety disorder. Analyzing these impurities aids in maintaining drug purity and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moexiprilat Impurities | Moexiprilat Impurities, crucial for quality control in pharmaceuticals, are studied to ensure purity in the production of moexipril, an antihypertensive medication. Understanding these impurities aids in refining the synthesis processes, significantly enhancing the safety and efficacy of drugs used to manage hypertension and cardiovascular conditions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moexipril Impurities | Moexipril Impurities hold a crucial role in the realm of pharmaceutical quality control and investigative studies of Moexipril, a potent antihypertensive agent. By scrutinizing purity, these impurities ensure the drug's safety and efficacy, facilitating advancements in cardiovascular therapeutics and enhancing the development of superior treatment modalities. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mofezolac | Mofezolac is a cyclooxygenase-1 selective inhibitor. Uses: Cyclooxygenase inhibitors. Group: Pharmaceutical. CAS No. 78967-07-4. Pack Sizes: 10 g. Product ID: B2693-008944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| MOG (35-55) | (MOG) 35-55 is a minor component of CNS myelin. Produces a relapsing-remitting neurological disease with extensive plaque-like demyelination. Group: Pharmaceutical. CAS No. 149635-73-4. Pack Sizes: 5 mg. Product ID: BAT-010068. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogrol | Mogrol is a natural compound isolated from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88930-15-8. Pack Sizes: 25 mg. Product ID: NP7047. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIA2 | Mogroside IIA2 is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-45-5. Pack Sizes: 10 mg. Product ID: B0005-465742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside III | Mogroside III is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 130567-83-8. Pack Sizes: 20 mg. Product ID: B0005-465747. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIIA1 | Mogroside IIIA1 is extracted from the fruits of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-42-2. Pack Sizes: 10 mg. Product ID: B0005-465741. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IIIe | Mogroside IIIe is an exquisite natural compound hailing from Siraitia grosvenorii, revered for its antioxidant prowess. This divine extract aids in studying ailments of oxidative magnitude. Group: Pharmaceutical. CAS No. 88901-37-5. Pack Sizes: 10 mg. Product ID: B0005-465743. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IV | Mogroside IV is extracted from the fruit of Siraitia grosvenorii Swingle. It exhibited maltase inhibitory effect. Group: Pharmaceutical. CAS No. 89590-95-4. Pack Sizes: 10 mg. Product ID: B2703-003393. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside IVa | Mogroside IVa is extracted from the fruit of Siraitia grosvenorii Swingle. Group: Pharmaceutical. CAS No. 88901-41-1. Pack Sizes: 10 mg. Product ID: B0005-465739. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mogroside V | Mogroside V is extracted from the fruit of Siraitia grosvenorii Swingle. It is 300 times sweeter than cane sugar and low in calories. It had a significant effect on insulin secretion and confirmed that the natural sweetener LHK could be beneficial for use by diabetic populations. Studies have found that mogrosides V have strong sweetness and functional effects. Group: Pharmaceutical. CAS No. 88901-36-4. Pack Sizes: 20 mg. Product ID: NP7008. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Molnupiravir Impurities | Molnupiravir Impurities, indispensable in the realm of biomedical scrutiny, function as critical benchmarks for ascertaining the synthesis fidelity of Molnupiravir. These impurities are central to maintaining the drugs structural integrity and antiviral potency against COVID-19, restraining viral expansion while upholding stringent regulatory and pharmacological standards. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Molsidomine Impurities | Molsidomine Impurities, prevalent in pharmaceuticals, play a crucial role in quality control and safety during the development of cardiovascular drugs. These impurities are analyzed to ensure the therapeutic efficacy and safety of molsidomine, a drug primarily used to treat angina pectoris by releasing nitric oxide, which dilates blood vessels. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate | Mometasone furoate, prodrug of the free form mometasone, is an agent with high affinity for the glucocorticoid receptor with anti-allergic property. It can be used to treat asthma and allergic rhinitis. Uses: The treatment of asthma and allergic rhinitis. Group: Pharmaceutical. CAS No. 83919-23-7. Pack Sizes: 5 g. Product ID: B0084-078204. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate EP Impurity D | An impurity of Mometasone furoate, which is a topical corticosteroid used as an anti-inflammatory. Group: Pharmaceutical. CAS No. 83881-09-8. Pack Sizes: 100 mg. Product ID: B1370-477792. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate EP Impurity E | An impurity of Mometasone furoate, which is a topical corticosteroid used as an anti-inflammatory. Group: Pharmaceutical. CAS No. 1370190-33-2. Pack Sizes: 100 mg. Product ID: B1370-477795. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate EP Impurity Q | An impurity of Mometasone furoate, which is a topical corticosteroid used as an anti-inflammatory. Group: Pharmaceutical. CAS No. 83881-08-7. Pack Sizes: 100 mg. Product ID: B1370-137126. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mometasone Furoate Impurities | Mometasone Furoate Impurities are utilized in the pharmaceutical industry to ensure the potency and safety of mometasone-based drugs. These impurities play a crucial role in the quality control process, aiding in the treatment of inflammatory dermatological conditions, such as eczema and psoriasis, by ensuring drug efficacy and regulatory compliance. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Momordicoside G | Momordicoside G is isolated from the herbs of Mormodica charantia L. Group: Pharmaceutical. CAS No. 81371-54-2. Pack Sizes: 1 mg. Product ID: NP6944. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Momordicoside K | Momordicoside K is a cucurbitacin found in Momordica charantia (bitter melon). Group: Pharmaceutical. CAS No. 81348-84-7. Pack Sizes: 1 mg. Product ID: NP7091. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Momordicoside L | Momordicoside L is a cucurbitacin found in Momordica charantia (bitter melon). Group: Pharmaceutical. CAS No. 81348-83-6. Pack Sizes: 1 mg. Product ID: NP7092. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monascin | Monascin is a pigment that displays more anti-atherosclerosis effect and less side effect involving increasing creatinine phosphokinase activity. Group: Pharmaceutical. CAS No. 21516-68-7. Pack Sizes: 1 mg. Product ID: B1359-250742. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monascus Pigment | Monascus Pigment is a natural compound renowned in the biomedical industry for its antimicrobial and anti-inflammatory properties. It is particularly effective in managing hyperlipidemia and hypertension. Additionally, Monascus Pigment contributes to the development of pharmaceutical agents targeting cardiovascular diseases and provides a basis for research into cholesterol metabolism mechanisms. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monepantel Impurities | Monepantel Impurities are critical in the pharmaceutical industry's quality control, particularly in the development of anthelmintic drugs targeting parasitic infections in livestock. These impurities help ensure the efficacy, safety, and purity of Monepantel, a leading agent in combating gastrointestinal nematodes without impacting non-target species. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monnieriside G | Monnieriside G is a chromone glycoside isolated from the fruits of Cnidium monnieri. Group: Pharmaceutical. CAS No. 1401799-34-5. Pack Sizes: 5 mg. Product ID: B0005-053486. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mono(6-(1,6-hexamethylenediamine)-6-deoxy)-beta-cyclodextrin | Mono(6-(1,6-hexamethylenediamine)-6-deoxy)-beta-cyclodextrin is a derivative of β-cyclodextrin, which can help improve the solubility of the drug in oral preparations or preparations. Group: Pharmaceutical. CAS No. 131991-61-2. Pack Sizes: 1 g. Product ID: B1999-286528. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mono(6-ethanediamine-6-deoxy)-beta-cyclodextrin | Mono(6-ethanediamine-6-deoxy)-beta-cyclodextrin is a versatile compound widely used in the biomedical industry. It acts as a molecular carrier aiding in the solubilization and stabilization of various drugs, including anti-cancer agents, antibiotics, and antivirals. Additionally, it exhibits potential therapeutic efficacy against various diseases such as Alzheimer's, HIV/AIDS, and diabetes. Group: Pharmaceutical. CAS No. 60984-63-6. Pack Sizes: 100 mg. Product ID: B2705-241634. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mono(6-mercapto-6-deoxy)-beta-cyclodextrin | Mono(6-mercapto-6-deoxy)-beta-cyclodextrin, a remarkable biomedicine, plays a pivotal role in addressing an array of ailments. Unveiling unparalleled drug delivery traits, it fuels the enhancement of drug solubility and stability. Embraced widely in the pharmaceutical realm, it powerfully ameliorates drug bioavailability while selectively targeting diverse maladies like cancer, infections, and inflammatory disorders. Group: Pharmaceutical. CAS No. 81644-55-5. Pack Sizes: 1 g. Product ID: B2705-286525. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mono-6-O-(p-toluenesulfonyl)-b-cyclodextrin | Mono-6-O-(p-toluenesulfonyl)-b-cyclodextrin, an indispensable compound in the biomedical sector, exhibits remarkable significance in augmenting the solubility, stability, and bioavailability of pharmaceuticals. Its vital function revolves around the formulation of diverse drugs, specifically those grappling with limited aqueous solubility. It finds extensive utilization within drug delivery systems, consequently fostering enhanced therapeutic effectiveness, thereby efficaciously combatting the targeted ailments. Group: Pharmaceutical. CAS No. 67217-55-4. Pack Sizes: 1 g. Product ID: B2705-286470. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monodes(N-carboxymethyl)valine Daclatasvir | Monodes(N-carboxymethyl)valine Daclatasvir is an impurity of Daclatasvir, a medication that is effective against hepatitis C virus (HCV). Group: Pharmaceutical. CAS No. 1007884-60-7. Pack Sizes: 10 mg. Product ID: B2694-341915. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mono-Hydroxy Sugammadex | Mono-Hydroxy Sugammadex is an impurity of sugammadex, a cyclodextrin agent indicated for the treatment of neuromuscular blockade induced by rocuronium and vecuronium. It inactivates rocuronium by encapsulating (chelating) the free molecule to form a stable complex. Group: Pharmaceutical. CAS No. 2376607-99-5. Pack Sizes: 2.5 mg. Product ID: B2694-370196. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monolinuron-[d6] | Monolinuron-[d6] is a deuterium labelled Monolinuron, an herbicide used to control broad-leaved weeds and annual grasses in vegetable crops. Group: Pharmaceutical. Pack Sizes: 10 mg. Product ID: BLP-014110. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monostearyl Maleate | Monostearyl Maleate. Group: Pharmaceutical. CAS No. 2424-62-6. Pack Sizes: 100 mg. Product ID: B0001-153014. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast Dicyclohexylamine Salt | Montelukast is a leukotriene D4-receptor antagonist used in the treatment of allergies and asthma. Uses: A selective leukotriene d4-receptor antagonist. used as an antiasthmatic. Group: Pharmaceutical. CAS No. 577953-88-9. Pack Sizes: 1 g. Product ID: B2692-263088. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast EP Impurity D | Montelukast EP Impurity D is an impurity of Montelukast, which is a leukotriene D4-receptor antagonist used in the treatment of allergies and asthma. Group: Pharmaceutical. CAS No. 1187586-61-3. Pack Sizes: 25 mg. Product ID: B2694-121121. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast EP Impurity E | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. CAS No. 1187586-58-8. Pack Sizes: 10 mg. Product ID: B2694-477814. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast Impurities | Montelukast Impurities play a crucial role in ascertaining the drug's purity and safety, particularly in therapeutic applications for asthma and allergic rhinitis. Through meticulous analysis of these impurities, researchers unravel insights into Montelukast's stability and therapeutic efficacy, optimizing its potential and minimizing risks in respiratory disease treatment. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast Related Impurity 1 | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. CAS No. 1258428-71-5. Pack Sizes: 25 mg. Product ID: B2694-477823. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast Related Impurity 2 | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. CAS No. 149968-11-6. Pack Sizes: 100 mg. Product ID: B1361-084543. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast S-Enantiomer Sodium Salt | An impurity of Montelukast Sodium, which is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. CAS No. 190078-45-6. Pack Sizes: 50 mg. Product ID: B2694-407610. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Montelukast Sodium Salt | Montelukast is a leukotriene receptor antagonist (LTRA) used for the maintenance treatment of asthma and to relieve symptoms of seasonal allergies. Group: Pharmaceutical. CAS No. 151767-02-1. Pack Sizes: 5 g. Product ID: B0084-059490. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Monuron-[d6] | Monuron-[d6] is the labelled analogue of Monuron, which is used as an herbicide for control of broad-leaved weeds. Group: Pharmaceutical. CAS No. 217488-65-8. Pack Sizes: 10 mg. Product ID: BLP-012463. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Morachalcone A | Morachalcone A is isolated from the roots of Morus alba. It exhibits potent inhibitory activity on nitric oxide production. Uses: Antioxidant activity; cytotoxic activity. Group: Pharmaceutical. CAS No. 76472-88-3. Pack Sizes: 1 mg. Product ID: NP0960. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moracin O | Moracin O isolated from the root bark of Morus alba L. Group: Pharmaceutical. CAS No. 123702-97-6. Pack Sizes: 5 mg. Product ID: NP4714. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moracin P | Moracin P isolated from the root bark of Morus alba L. Group: Pharmaceutical. CAS No. 102841-46-3. Pack Sizes: 5 mg. Product ID: NP4654. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Morin | Morin induces caspase-dependent apoptosis through extrinsic pathway by upregulating Fas receptor as well as through the intrinsic pathway by modulating Bcl-2 and IAP family members. Uses: Anti-cancer. Group: Pharmaceutical. CAS No. 480-16-0. Pack Sizes: 100 g. Product ID: B2703-092919. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moringin | Moringin is a natural compound isolated from the seeds of Moringa oleifera. Moringin is a potent and selective TRPA1 ion channel agonist with an EC50 of 3.14 μM. Group: Pharmaceutical. CAS No. 73255-40-0. Pack Sizes: 10 mg. Product ID: NP4836. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Morin hydrate | Morin is a natural compound isolated from Maclura pomifera (Osage orange). Morin induces caspase-dependent apoptosis through extrinsic pathway by upregulating Fas receptor as well as through the intrinsic pathway by modulating Bcl-2 and IAP family members. Uses: Anti-cancer. Group: Pharmaceutical. CAS No. 654055-01-3. Pack Sizes: 100 g. Product ID: B2703-465104. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moronic acid | Moronic acid isolated from the herbs of Rhus chinensis. It shows oral therapeutic efficacy in HSV-infected mice and possessed novel anti-HSV activity. Uses: Anti-hiv;anti-hsv;anti-ebv. Group: Pharmaceutical. CAS No. 6713-27-5. Pack Sizes: 1 mg. Product ID: NP6250. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Moroxydine Impurities | Moroxydine Impurities, integral to rigorous quality control and antiviral pharmacology, bear paramount importance in the precise targeting of influenza and various viral maladies. These constituents attest to Moroxydine's purity and efficacy, fortifying its status as a vital antiviral arsenal in the sophisticated battle against viral afflictions. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Morusin | Morusin is a prenylated flavonoid isolated from the root bark of Morus alba L. It exhibits antioxidant and anti-inflammatory activity. Uses: Antinociceptive; anti-oxidant and anti-inflammatory effects. Group: Pharmaceutical. CAS No. 62596-29-6. Pack Sizes: 25 mg. Product ID: NP1898. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Morusinol | Morusinol is a natural flavonoid found in the root bark of Morus alba L, it inhibits arterial thrombosis in vivo due to antiplatelet activity. Uses: Antiplatelet. Group: Pharmaceutical. CAS No. 62949-93-3. Pack Sizes: 5 mg. Product ID: NP1965. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mosapride Citrate Dihydrate | Mosapride Citrate Dihydrate is a citrate hydrate form of Mosapride, which is a 5-HT4 receptor agonist and 5-HT3 receptor antagonist. It is used as a gastroprokinetic agent. Group: Pharmaceutical. CAS No. 636582-62-2. Pack Sizes: 1 g. Product ID: B0084-059885. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
| Mosapride Impurities | Mosapride Impurities, comprising diverse chemical entities, are indispensable reference standards in pharmaceutical research. Their critical function lies in ensuring quality control and fostering the development of therapeutics for gastrointestinal ailments, notably those affecting motility, including gastroesophageal reflux disease (GERD) and functional dyspepsia, thereby enhancing drug efficacy and safety profiles. Group: Pharmaceutical. Pack Sizes: 1mg; 1g; 10g. Molecular formula: Custom synthesis is available. Send your inquiries for more information. | London |
Would you like to list your products on UK Chemical Suppliers?
Our database is helping our users find suppliers everyday.